Publication

Article

The American Journal of Managed Care

August 2008
Volume14
Issue 8

Participant Disclosure (Am J Manag Care. 2008;14[suppl 8]:S241-S268)

Our July 2008 supplement on Biologics and Benefit Design, funded by Amgen Inc, (Am J Manag Care. 2008;14[suppl 8]:S241-S268), included an error of omission on the Participant Disclosures page.

The following disclosures for Robert Berglund should have been noted on S244:

Robert Berglund

Honoraria, Amgen Inc

Download PDF: Participant Disclosure (Am J Manag Care. 2008;14[suppl 8]:S241-S268)

Articles in this issue
Participant Disclosure (Am J Manag Care. 2008;14[suppl 8]:S241-S268)
Agreement Between Patient-reported Symptoms and Their Documentation in the Medical Record
A Meta-analysis Update: Percutaneous Coronary Interventions
Managed Care Enrollment and Chronically Disabled Women With Breast Cancer
Medicare HMO Impact on Utilization at the End of Life
Strategies for Identifying and Channeling Patients for Depression Care Management
Flunking Asthma? When HEDIS Takes the ACT
Related Videos
Related Content
AJMC
December 17th 2024

A Standardized Care Pathway Increases Optimal Dialysis Starts

Roy G. Marcus, MD David M. Miller, MBA Brian H. Nathanson, PhD Douglas Eckhardt, MBA Steven Henry, PharmD Katherine Kwon, MD Rohit Sharma, MD Nirav Vakharia, MD
The authors observed a significant increase in optimal starts for dialysis and in peritoneal dialysis rates after implementing a standardized end-stage renal disease transition pathway.
AJMC
December 16th 2024

Uptake of Rituximab Biosimilars in Medicare and Medicaid in 2019-2022

Jingjing Qian, PhD
Significant uptake of rituximab biosimilars in Medicare and Medicaid occurred within the first 4 years of marketing in the US.
Addressing STIs Through Managed Care: Opportunities in Medicaid and Beyond
December 16th 2024

Addressing STIs Through Managed Care: Opportunities in Medicaid and Beyond

Naomi Seiler, JD Katie Horton, JD, RN, MPH Paige Organick-Lee, MPH Mekhi Washington, BS Taylor Turner, MPH William S. Pearson, PhD, MHA
Medicaid and other managed care organizations could take several key steps to respond to the sexually transmitted infection (STI) epidemic in the US, including congenital syphilis.
AJMC
December 13th 2024

Cost-Effectiveness of a Multicancer Early Detection Test in the US

Anuraag R. Kansal, PhD Ali Tafazzoli, PhD Alissa Shaul, MPH Ameya Chavan, MS Weicheng Ye, MPH Denise Zou, MA A. Mark Fendrick, MD
Multicancer early detection testing results in extended life-years and reduced cancer treatment costs through earlier diagnosis, leading to a cost-effective option in cancer screening.
Provider Capacity During Medicaid Expansion and a Public Health Emergency
December 13th 2024

Provider Capacity During Medicaid Expansion and a Public Health Emergency

Jake Haselswerdt, PhD Kristi Ressel, MPH Emmie Harcourt, MPA Sara Gable, PhD Kathleen Quinn, PhD
This survey study finds that most Missouri Medicaid providers had capacity for new patients, even during a period of unprecedented Medicaid enrollment growth.
Park City Utah | Image Credit: © SeanPavonePhoto - stock.adobe.com
December 12th 2024

Transforming Kidney Care: Policy, Risk Stratification, and Collaborative Models

Kyle Munz
Experts at a recent Institute for Value-Based Medicine event emphasized the importance of early intervention, policy innovation, and proactive collaboration to transform the management of kidney disease and optimize patient outcomes.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo